Healthcare Industry News: K2M
News Release - September 15, 2009
K2M Launches NATURAL BRIDGE Low Profile Transverse ConnectorsLEESBURG, Va., Sept. 15--(HSMN NewsFeed)--K2M, Inc., the spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced the launch of the NATURAL BRIDGE® Low Profile (LP) Transverse Connectors to provide optimal torsional stabilization in the thoracolumbar spine. The uniquely designed low volume polyaxial heads snap onto the rod, allowing for ease of introduction while offering the surgeon tactile feedback when implanting.
NATURAL BRIDGE LP incorporates both adjustable and semi-adjustable designs for use with K2M’s RANGE®, MESA®, and DENALI® Spinal Systems. The ultra low profile pairs especially well with MESA’s unique, no profile above the rod design. The telescoping design of the adjustable connector ensures a pathology-specific custom fit. The semi-adjustable connectors combine the rigid center body of a fixed connector with the polyaxial heads of an adjustable design, thus eliminating the need for bending the connector during insertion.
According to Dr. Joseph Flynn, Jr., Orthopedic Surgeon at The Spine and Scoliosis Center, “NATURAL BRIDGE LP probably has the lowest profile I have seen on the market. The connectors are simple and easy to insert.”
“The NATURAL BRIDGE LP Transverse Connectors are an important introduction for K2M, because the ultra low profile design of this system compliments the clinical advantages of the MESA no profile technology,” stated Eric Major, K2M’s President and CEO. “The launch of NATURAL BRIDGE LP moves us one step closer to providing a full portfolio of differentiated products to address all spinal pathologies.”
K2M, Inc. is an innovative spinal device company committed to the research, development, and commercialization of simplified solutions for the treatment of complex spinal pathologies and procedures. Chief Medical Officer, Chairman and co-founder, Dr. John Kostuik, former Chief of Spine Surgery at The Johns Hopkins University School of Medicine, drives K2M’s commitment to redefining the market. The company is recognized as a worldwide leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s complete portfolio of next generation products includes: spinal stabilization systems, minimally invasive systems, and other advancing technologies such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.